Яд или лекарство? Как растения, порошки и таблетки повлияли на историю медицины - Томас Хэджер

Disease in Adults: Systematic Review for the U.S. Preventive Services Task Force.” AHRQ Publication No. 14–05206-EF-2 (Dec. 2015).

Aldrich, Michael R. “Historical Notes on Women Addicts.” J Psychoactive Drugs 26, no. 1 (1994): 61–64.

Alexander, G. Caleb, et al. “Increasing Off-Label Use of Antipsychotic Medications in the United States, 1995–2008.” Pharmacoepidemio. Drug Saf 20, no. 2 (2011): 177–218.

Aravamudan, Srinivas. “Lady Mary Wortley Montagu in the Hammam; Masquerade, Womanliness, and Levantinization.” ELH 62, no.1 (1995): 69–104.

Asbell, Bernard. The Pill: A Biography of the Drug that Changed the World. New York: Random House, 1995.

Ayd, Frank J., and Barry Blackwell. Discoveries in Biological Psychiatry. Philadelphia: J. B. Lippincott Co, 1970.

Ban, Thomas, et al, eds. Reflections on Twentieth-Century Psychopharmacology. Scotland, UK: CINP, 2004.

Ban, Thomas A. “The Role of Serendipity in Drug Discovery.” Dialogues Clin Neurosci 8, no. 3 (2006): 335–44.

Bard, Solomon. “Tea and Opium.” J Hong Kong Branch R Asiat Soc 40 (2000): 1–19.

Barrett, Bruce, et al. “Communicating Statin Evidence to Support Shared Decision-Making.” BMC Fam Pract 17 (2016): 41.

Baumeister, A. “The Chlorpromazine Enigma.” J Hist Neurosci 22, no. 1 (2013): 14–29.

Behbehani, Abbas M. “The Smallpox Story: Life and Death of an Old Disease.” Microbiol Rev 47, no. 4 (1983): 455–509.

Berger, Philip A. “Medical Treatment of Mental Illness.” Science 200, no. 4344 (1978): 974–81.

Berger, Samantha, et al. “Dietary Cholesterol and Cardiovascular Disease: A Systematic Review and Meta-Analysis.” Am J Clin Nutr 102 (2015): 276–94.

Black, Sir James. “A Personal Perspective on Dr. Paul Janssen.” J Med Chem 48 (2005): 1687–88.

Booth, Martin. Opium: A History. New York: St. Martin’s Press, 1998.

Boylston, Arthur. “The Origins of Inoculation.” J R Soc Med 105 (2012): 309–13.

Brown, Michael S., and Joseph L. Goldstein. “A Tribute to Akira Endo, Discoverer of a ‘Penicillin’ for Cholesterol.” Atheroscler Suppl 5 (2004): 13–16.

Brown, Thomas H. “The African Connection.” JAMA 260, no. 15 (1988): 2,247–9.

Brownstein, Michael. “A Brief History of Opiates, Opiod Peptides, and Opiod Receptors.” Proc Natl Acad Sci USA 90 (1993): 5,391–3.

Burns, Tom. Psychiatry: A Very Short Introduction. Oxford: Oxford University Press, 2006.

Buss, Nicholas, et al. “Monoclonal Antibody Therapeutics: History and Future.” Curr Opinion in Pharmacology 12 (2012): 615–22.

Caldwell, Anne E. Origins of Psychopharmacology: From CPZ to LSD. Springfield, IL: Charles C. Thomas, 1970.

Campbell, S. F. “Science, Art and Drug Discovery: A Personal Perspective.” Clin Sci 99 (2000): 255–60.

Carter, Paul J. “Potent Antibody Therapeutics by Design.” Nat Rev Immunol 6 (2006): 343–57.

Cholesterol Treatment Trialists’ Collaborators. “The Effects of Lowering LDL Cholesterol with Statin Therapy in People at Low Risk of Vascular Disease: Meta-Analysis of Individual Data from 27 Randomized Trials.” Lancet 380 (2012): 581–90.

Courtwright, David T. “A Century of American Narcotic Policy.” In Treating Drug Problems: Volume 2: Commissioned Papers on Historical, Institutional, and Economic Contexts of Drug Treatment, edited by Gerstein, D. R., and H. J. Harwood. Washington, D.C.: National Academies Press, 1992.

––. “The Cycles of American Drug Policy.” History Faculty Publications 25 (2015): https://digitalcommons.unf.edu/ahis_facpub/25.

––. “Preventing and Treating Narcotic Addiction—A Century of Federal Drug Control.” NEJM 373, no. 22 (2015): 2095–7.

Covington, Edward C. “Opiophobia, Opiophilia, Opioagnosia.” Pain Med 1, no. 3 (2000): 217–23.

de Lorgeril, Michel, and Mikael Rabaeus. “Beyond Confusion and Controversy, Can We Evaluate the Real Efficacy and Safety of Cholesterol-Lowering with Stains?” JCBR 1, no. 1 (2015): 67–92.

de Ridder, Michael. “Heroin: New Facts About an Old Myth.” J Psychoactive Drugs 26, no. 1 (1994): 65–68.

Defalque, Ray, and Amos J. Wright. “The Early History of Methadone: Myths and Facts.” Bull Anesth Hist 25, no. 3 (2007): 13–16.

de Ropp, Robert. Drugs and the Mind. New York: Grove Press, 1961.

Dhont, Marc. “History of Oral Contraception.” Eur J Contracept Reprod Health Care 15(sup2) (2010): S12–S18.

Diamond, David M., and Uffe Ravnskov. “How Statistical Deception Created the Appearance that Statins Are Safe and Effective in Primary and Secondary Prevention of Cardiovascular Disease. Expert Rev Clin Pharmacol (2015): Early online, 1–10.

Dinc, Gulten, and Yesim Isil Ulman. “The Introduction of Variolation ‘A La Turca’ to the West by Lady Mary Montagu and Turkey’s Contribution to This.” Vaccine 25 (2007): 4,261–5.

Djerassi, Carl. “Ludwig Haberlandt – ‘Grandfather of the Pill.’” Wien Klin Wochenschr 121 (2009): 727–8.

Dormandy, Thomas. The Worst of Evils: The Fight Against Pain. New Haven: Yale University Press, 2006.

––. Opium: Reality’s Dark Dream. New Haven: Yale University Press, 2012.

Dowbiggin, Ian. The Quest for Mental Health: A Tale of Science, Scandal, Sorrow, and Mass Society. Cambridge, UK: Cambridge University Press, 2011.

DuBroff, Robert, and Michel de Lorgeril. “Cholesterol Confusion and Statin Controversy.” World J Cardiol 7, no. 7 (2015): 404–9.

Eddy, Nathan B. “The History of the Development of Narcotics.” Law Contemp Probl 22, no. 1 (1957): 3–8.

Eichmann, Klaus. Köhler’s Invention. Basel: Birkhäuser Verlag, 2005.

Eisenberg, Leon. “Mindlessness and Brainlessness in Psychiatry.” Brit J Psychiatry 148 (1986): 497–508.

––. “Were We All Asleep at the Switch? A Personal Reminiscence of Psychiatry from 1940 to 2010.” Acta Psychiatr Scand 122 (2010): 89–102.

Endo, Akido. “A Historical Perspective on the Discovery of Statins.” Proc Jpn Acad Ser B Phys Biol Sci 86 (2010): 484–93.

Fitchett, David H., et al. “Statin Intolerance.” Circulation 131 (2015): e389–e391.

Garbarino, Jeanne. “Cholesterol and Controversy: Past, Present, and Future.” Scientific American (blog), November 15, 2011. https://blogs.scientificamerican.com/guest-blog/cholesterol-confusion-and-why-we-should-rethink-our – approach-to-statin-therapy/.

Gasperskaja, Evelina, and Vaidutis Kučinskas. “The Most Common Technologies and Tools for functional Genome Analysis.” Acta Med Litu 24, no. 1 (2017): 1–11.

Gershell, Leland J., and Joshua H. Atkins. “A Brief History of Novel Drug Technologies.” Nat Rev Drug Discov 2 (2003): 321–7.

Goldin, Claudia, and Lawrence F. Katz. “The Power of the Pill: Oral Contraceptives and Women’s Career and Marriage Decisions.” J Polit Econ 110, no. 4 (2002): 730–70.

Goldstein, Irwin. “The Hour Lecture That Changed Sexual Medicine—the Giles Brindley Injection Story.” J Sex Med 9, no. 2 (2012): 337–42.

Goldstein, Joseph L., and Michael S. Brown. “A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins.” Cell 161 (2015): 161–72.

Greene, Jeremy A. Prescribing